Section 29 (New Zealand) in Oman
How the section 29 (new zealand) pathway operates in Oman.
About Section 29 (New Zealand)
New Zealand's Medsafe pathway for unapproved medicines.
How Section 29 (New Zealand) works in Oman
Oman's MoH operates a personal-import pathway; volumes are smaller but the pathway is functional for rare-disease and specialty needs.
Patients in Oman seeking access under Section 29 (New Zealand) typically follow this flow: a licensed physician in Oman issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Oman
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.